Free PSA/total PSA ratio increases the detection rate of prostate cancer in twelve-core biopsy.
BACKGROUND
In the present study, we compared 12- with 8-core biopsy in patients with prostate-specific antigen (PSA) levels of 4.0-20.0 ng/ml. We also examined whether the free/total (F/T) PSA ratio is useful for cancer detection in 12-core biopsy.


METHODS
A total of 419 men with PSA level between 4.0 and 20.0 ng/ml underwent transrectal ultrasound-guided transperineal needle biopsies of the prostate. Of these men, 235 underwent 8-core biopsy and 184 underwent 12-core biopsy. We compared the cancer detection rate between the 8- and 12-core biopsy groups by analyzing the PSA value, and especially the F/T PSA ratio.


RESULTS
The cancer detection rate in the 12-core group (35.9%) was significantly higher than in the 8-core group (23.8%). In cases of PSA level of 4.0-20.0 ng/ml with F/T PSA ratio less than 0.11, the cancer detection rate was 53.1% in the 12-core biopsy group. Performing 12-core biopsy resulted in a marked difference of cancer detection rate between men with F/T PSA ratio less than 0.11 and those with more than 0.12 in gray zone PSA (48.2% and 17.5%, respectively).


CONCLUSIONS
Twelve-core biopsy can achieve a higher detection rate of prostate cancer than 8-core biopsy using F/T PSA ratio.
Yokomizo
Yumiko
Y
Department of Urology, Yokohama City University Graduate School of Medicine, Kanazawa-ku, Yokohama, Japan.
Miyoshi
Yasuhide
Y
Nakaigawa
Noboru
N
Makiyama
Kazuhide
K
Ogawa
Takehiko
T
Yao
Masahiro
M
Kubota
Yoshinobu
Y
Uemura
Hiroji
H
D000368:Aged; D001707:Biopsy, Needle / Q000379:methods; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011237:Predictive Value of Tests; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000276:immunology / Q000473:pathology; D012372:ROC Curve; D018084:Ultrasonography, Interventional
D017430:Prostate-Specific Antigen